{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:22:26Z","timestamp":1762928546421},"reference-count":27,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Delayed consequences of spinal radiotherapy (RT), including vertebral compression fracture (VCF), are critical complications. However, the predisposing factors that contribute to VCF after conventional RT are unclear. The aim of this study was to assess the incidence of VCF and to determine the predictors of VCF following conventional spinal RT specific to colorectal cancer (CRC).<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The authors retrospectively reviewed 237 spinal segments (147 metastatic and 90 nonmetastatic) in 53 patients with CRC who underwent RT with a median total dose of 30 Gy in 10 fractions between January 2007 and December 2014. The primary end point was the development of a VCF following RT, either de novo VCF or the progression of a baseline VCF. VCFs were assessed using the spinal instability neoplastic score (SINS) criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Among all 237 spinal segments, 22 VCFs (9.3%) were observed following RT, including 13 de novo and 9 progressive fractures, and the median time to VCF was 4 months. All VCFs developed in metastatic spines. Among 147 metastatic spinal segments, 22 fractures were observed, with a 12-month cumulative incidence of VCF of 14.8%. Results of multivariable analysis indicated sex (p = 0.023) and SINS class II\/III (p &lt; 0.001) as risk factors related to development of a VCF in metastatic spinal segments. Among the SINS criteria, a lytic tumor and the presence of a baseline VCF were identified as predictors of VCF in metastatic spinal segments.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>In osteolytic or mixed lesions that were predominant in spinal metastases of CRC, the incidence of VCF was not negligible, even in patients treated with conventional spinal RT. This was especially evident in patients with spinal metastases with a SINS score \u2265 7. Presence of a baseline VCF after spinal RT is a predictor of VCF development and should be observed carefully.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2017.6.spine17282","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T15:03:18Z","timestamp":1513954998000},"page":"333-340","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of predictive factors of vertebral compression fracture after conventional palliative radiotherapy for spinal metastasis from colorectal cancer"],"prefix":"10.3171","volume":"28","author":[{"given":"Jeongshim","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul;"},{"name":"Department of Radiation Oncology, Inha University Hospital, Incheon; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Joong","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Suk","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei Kyung","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woong Sub","family":"Koom","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3171\/2013.2.SPINE12739","article-title":"Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery: clinicopathological correlation","volume":"18","author":"Al-Omair A","year":"2013","unstructured":"Al-Omair A, Smith R, Kiehl TR, Lao L, Yu E, Massicotte EM, : Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery: clinicopathological correlation. J Neurosurg Spine 18:430\u2013435, 20132349588910.3171\/2013.2.SPINE12739"},{"key":"b2","series-title":"BMC Cancer","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12885-016-2102-y","article-title":"A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX\/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)","volume":"16","author":"Avallone A","year":"2016","unstructured":"Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, : A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX\/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme). BMC Cancer 16:69, 201610.1186\/s12885-016-2102-y26857924"},{"key":"b3","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3171\/2011.11.SPINE116","article-title":"Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases","volume":"16","author":"Boehling NS","year":"2012","unstructured":"Boehling NS, Grosshans DR, Allen PK, McAleer MF, Burton AW, Azeem S, : Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases. J Neurosurg Spine 16:379\u2013386, 20122222548810.3171\/2011.11.SPINE116"},{"key":"b4","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"Boonen S","year":"2012","unstructured":"Boonen S, Reginster JY, Kaufman JM, Lippuner K, Zanchetta J, Langdahl B, : Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med 367:1714\u20131723, 20122311348210.1056\/NEJMoa1204061"},{"key":"b5","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","article-title":"Palliative radiotherapy trials for bone metastases: a systematic review","volume":"25","author":"Chow E","year":"2007","unstructured":"Chow E, Harris K, Fan G, Tsao M, Sze WM: Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25:1423\u20131436, 20071741686310.1200\/JCO.2006.09.5281"},{"key":"b6","series-title":"Clin Oncol (R Coll Radiol)","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases","volume":"24","author":"Chow E","year":"2012","unstructured":"Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S: Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 24:112\u2013124, 20122213063010.1016\/j.clon.2011.11.004"},{"key":"b7","series-title":"J Am Stat Assoc","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine JP","year":"1999","unstructured":"Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509, 199910.1080\/01621459.1999.10474144"},{"key":"b8","series-title":"Spine (Phila Pa 1976)","first-page":"E1221","article-title":"A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group","volume":"35","author":"Fisher CG","year":"2010","unstructured":"Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, : A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 35:E1221\u2013E1229, 2010"},{"key":"b9","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1200\/JCO.2010.34.3897","article-title":"Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group","volume":"29","author":"Fourney DR","year":"2011","unstructured":"Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, : Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 29:3072\u20133077, 201110.1200\/JCO.2010.34.3897"},{"key":"b10","series-title":"Ann Stat","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray RJ","year":"1988","unstructured":"Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141\u20131154, 198810.1214\/aos\/1176350951"},{"key":"b11","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S1470-2045(14)70377-8","article-title":"Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial","volume":"15","author":"Hong YS","year":"2014","unstructured":"Hong YS, Nam BH, Kim KP, Kim JE, Park SJ, Park YS, : Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Lancet Oncol 15:1245\u20131253, 201410.1016\/S1470-2045(14)70377-825201358"},{"key":"b12","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3171\/2015.10.SPINE141261","article-title":"Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation","volume":"24","author":"Jawad MS","year":"2016","unstructured":"Jawad MS, Fahim DK, Gerszten PC, Flickinger JC, Sahgal A, Grills IS, : Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation. J Neurosurg Spine 24:928\u2013936, 20162689552610.3171\/2015.10.SPINE141261"},{"key":"b13","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell O","year":"2006","unstructured":"Johnell O, Kanis JA: An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726\u20131733, 200610.1007\/s00198-006-0172-416983459"},{"key":"b14","series-title":"Dis Colon Rectum","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1007\/BF02236213","article-title":"Skeletal metastases in colorectal carcinomas: a Saskatchewan profile","volume":"42","author":"Kanthan R","year":"1999","unstructured":"Kanthan R, Loewy J, Kanthan SC: Skeletal metastases in colorectal carcinomas: a Saskatchewan profile. Dis Colon Rectum 42:1592\u20131597, 19991061347910.1007\/BF02236213"},{"key":"b15","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ijrobp.2015.06.006","article-title":"Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: role of spinal instability and single-fraction radiation therapy","volume":"93","author":"Lam TC","year":"2015","unstructured":"Lam TC, Uno H, Krishnan M, Lutz S, Groff M, Cheney M, : Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: role of spinal instability and single-fraction radiation therapy. Int J Radiat Oncol Biol Phys 93:373\u2013381, 20152627932410.1016\/j.ijrobp.2015.06.006"},{"key":"b16","series-title":"Oncologist","first-page":"615","article-title":"Phase II trial of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: 5-year clinical outcomes ECOG-ACRIN Cancer Research Group E3204","volume":"20","author":"Landry JC","year":"2015","unstructured":"Landry JC, Feng Y, Prabhu RS, Cohen SJ, Staley CA, Whittington R, : Phase II trial of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: 5-year clinical outcomes ECOG-ACRIN Cancer Research Group E3204. Oncologist 20:615\u2013616, 201525926352"},{"key":"b17","series-title":"Radiat Oncol J","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3857\/roj.2014.32.4.221","article-title":"Vertebral compression fractures after spine irradiation using conventional fractionation in patients with metastatic colorectal cancer","volume":"32","author":"Rhee WJ","year":"2014","unstructured":"Rhee WJ, Kim KH, Chang JS, Kim HJ, Choi S, Koom WS: Vertebral compression fractures after spine irradiation using conventional fractionation in patients with metastatic colorectal cancer. Radiat Oncol J 32:221\u2013230, 20142556885010.3857\/roj.2014.32.4.221"},{"key":"b18","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"R\u00f6del C","year":"2015","unstructured":"R\u00f6del C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, : Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 16:979\u2013989, 201510.1016\/S1470-2045(15)00159-X26189067"},{"key":"b19","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","article-title":"Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases","volume":"27","author":"Rose PS","year":"2009","unstructured":"Rose PS, Laufer I, Boland PJ, Hanover A, Bilsky MH, Yamada J, : Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 27:5075\u20135079, 200910.1200\/JCO.2008.19.350819738130"},{"key":"b20","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen LS","year":"2004","unstructured":"Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsh V, Krzakowski M, : Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial. Cancer 100:2613\u20132621, 200410.1002\/cncr.2030815197804"},{"key":"b21","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal A","year":"2013","unstructured":"Sahgal A, Atenafu EG, Chao S, Al-Omair A, Boehling N, Balagamwala EH, : Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol 31:3426\u20133431, 20132396017910.1200\/JCO.2013.50.1411"},{"key":"b22","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1016\/S1470-2045(13)70101-3","article-title":"Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases","volume":"14","author":"Sahgal A","year":"2013","unstructured":"Sahgal A, Whyne CM, Ma L, Larson DA, Fehlings MG: Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases. Lancet Oncol 14:e310\u2013e320, 201310.1016\/S1470-2045(13)70101-3"},{"key":"b23","series-title":"Ann Oncol","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1093\/annonc\/mdr572","article-title":"Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study","volume":"23","author":"Santini D","year":"2012","unstructured":"Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, : Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol 23:2072\u20132077, 201210.1093\/annonc\/mdr57222219016"},{"key":"b24","series-title":"Am J Pathol","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.2353\/ajpath.2006.050566","article-title":"Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential","volume":"169","author":"Schl\u00fcter K","year":"2006","unstructured":"Schl\u00fcter K, Gassmann P, Enns A, Korb T, Hemping-Bovenkerk A, H\u00f6lzen J, : Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol 169:1064\u20131073, 200610.2353\/ajpath.2006.05056616936278"},{"key":"b25","series-title":"Health Technol Assess","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17420","article-title":"A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression","volume":"17","author":"Sutcliffe P","year":"2013","unstructured":"Sutcliffe P, Connock M, Shyangdan D, Court R, Kandala NB, Clarke A: A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression. Health Technol Assess 17:1\u2013274, 20132407011010.3310\/hta17420"},{"key":"b26","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(15)00216-8","article-title":"Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial","volume":"16","author":"Tournigand C","year":"2015","unstructured":"Tournigand C, Chibaudel B, Samson B, Scheithauer W, Vernerey D, M\u00e9sange P, : Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial. Lancet Oncol 16:1493\u20131505, 20152647451810.1016\/S1470-2045(15)00216-8"},{"key":"b27","series-title":"Cancer Res Treat","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.4143\/crt.2015.207","article-title":"Variation in practice patterns of Korean radiation oncologists for spine metastasis between 2009 and 2014","volume":"48","author":"Yu JI","year":"2016","unstructured":"Yu JI, Park HC, Ahn YC, Chung Y, Koom WS, Song SY: Variation in practice patterns of Korean radiation oncologists for spine metastasis between 2009 and 2014. Cancer Res Treat 48:1102\u20131109, 201610.4143\/crt.2015.20726639199"}],"container-title":["Journal of Neurosurgery: Spine"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/28\/3\/article-p333.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/28\/3\/article-p333.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/28\/3\/article-p333.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T23:59:09Z","timestamp":1681603149000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/28\/3\/article-p333.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2017.6.spine17282","relation":{},"ISSN":["1547-5654"],"issn-type":[{"value":"1547-5654","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}